Company Search:
Advanced Search
Sponsored Links
Aquestive Therapeutics Inc Company Snapshot
Aquestive Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aquestive Therapeutics Inc with three other companies in this sector in UNITED STATES : Fortress Biotech Inc (2020 sales of $45.60 million of which 98% was Dermatology Product), Morphic Holding Inc ($44.95 million of which 100% was Biopharmaceutical), and Dynavax Technologies Corporation ($46.55 million of which 77% was HEPLISAV-B).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aquestive Therapeutics Inc
  Stock Performance Chart for Aquestive Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 4.23
(Figures in U.S. Dollars)
1 Week 14.3%   13 Weeks 23.3%  
4 Weeks -20.3%   52 Weeks -10.9%  
Aquestive Therapeutics Inc Key Data:
  Ticker: AQST Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 45,849,000
(Year Ending Jan 2021).
Employees: 187
  Currency: U.S. Dollars Market Cap: 153,300,944
  Fiscal Yr Ends: December Shares Outstanding: 36,241,358
  Share Type: Common Closely Held Shares: 3,975,535
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.